BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 32828968)

  • 21. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Ancillary Techniques in Cervical Biopsy and Endocervical Curettage Specimens as Follow-Up to Papanicolaou Test Results Indicating a Diagnosis of Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion, or High-Grade Squamous Intraepithelial Lesion.
    Jenkins TM; Shojaei H; Song SJ; Schwartz LE
    Acta Cytol; 2020; 64(1-2):155-165. PubMed ID: 30982025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings.
    Ratnam S; Jang D; Gilbert L; Alaghehbandan R; Schell M; Needle R; Ecobichon-Morris A; Wang PP; Rahman M; Costescu D; Elit L; Zahariadis G; Chernesky M
    Papillomavirus Res; 2020 Dec; 10():100206. PubMed ID: 32828968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.
    Gilbert L; Ratnam S; Jang D; Alaghehbandan R; Schell M; Needle R; Ecobichon-Morris A; Wadhawan A; Costescu D; Elit L; Wang P; Zahariadis G; Chernesky M
    Cancer Biomark; 2022; 34(3):347-358. PubMed ID: 35001877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M; Christensen RK; Ørnskov D
    Cancer Cytopathol; 2013 Mar; 121(3):136-45. PubMed ID: 22987560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
    Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I; Valasoulis G; Founta C; Kyrgiou M; Nasioutziki M; Daponte A; Koliopoulos G; Malamou-Mitsi V; Karakitsos P; Paraskevaidis E
    Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of p16/Ki-67 dual-staining cytology in cervical cancers.
    Yu L; Fei L; Liu X; Pi X; Wang L; Chen S
    J Cancer; 2019; 10(12):2654-2660. PubMed ID: 31258773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in immunocytochemical staining for cervical cancer screening.
    Sun H; Shen K; Cao D
    Cancer Manag Res; 2019; 11():1817-1827. PubMed ID: 30863187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
    Peeters E; Wentzensen N; Bergeron C; Arbyn M
    Cancer Cytopathol; 2019 Mar; 127(3):169-180. PubMed ID: 30811902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis on the performance of p16/Ki-67 dual immunostaining in detecting high-grade cervical intraepithelial neoplasm.
    Sun M; Shen Y; Ren ML; Dong YM
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S587-S593. PubMed ID: 30249873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.
    Tainio K; Athanasiou A; Tikkinen KAO; Aaltonen R; Cárdenas J; Hernándes ; Glazer-Livson S; Jakobsson M; Joronen K; Kiviharju M; Louvanto K; Oksjoki S; Tähtinen R; Virtanen S; Nieminen P; Kyrgiou M; Kalliala I
    BMJ; 2018 Feb; 360():k499. PubMed ID: 29487049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review.
    Tjalma WAA
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():275-280. PubMed ID: 28086168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact on women's health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium.
    Tjalma WAA; Kim E; Vandeweyer K
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():171-181. PubMed ID: 28081908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.
    Arbyn M; Xu L; Verdoodt F; Cuzick J; Szarewski A; Belinson JL; Wentzensen N; Gage JC; Khan MJ
    Ann Intern Med; 2017 Jan; 166(2):118-127. PubMed ID: 27842420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
    Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R;
    Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.
    Wright TC; Stoler MH; Behrens CM; Sharma A; Zhang G; Wright TL
    Gynecol Oncol; 2015 Feb; 136(2):189-97. PubMed ID: 25579108
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.